A company-specific look at CRISPR Therapeutics, the current market theme surrounding CRSP, its operating relevance and the evidence needed to assess what follows.

Clayface 2026 opens Oct. 23 as DC Studios' first R-rated horror film. The villain's serum -- a treatment that corrects one ...

Unreal Engine 5 enabled Duncan Jones to bring Rogue Trooper to TIFF 2026 as a fully independent animated feature, proving ...

Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long alarmed bioethicists. By Carl Zimmer Scientists at Columbia University have ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. CRISPR-mediated gene editing technology has ...

Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition succeeded in a Phase 3 trial, a landmark for gene editing. The treatment uses Nobel Prize-winning Crispr technology ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that causes Down syndrome (DS). Down syndrome is a genetic condition caused by an ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, ...